March 5, 2023

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – YMAB

NEW YORK, March 04, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) between October 6, 2020 and October 28, 2022, both dates inclusive (the “Class Period”), of the important March 20, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Y-mAbs securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Y-mAbs class action, go to https://rosenlegal.com/submit-form/?case_id=9496 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 20, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the Complaint, the Company made false and misleading statements to the market. Y-mAbs repeatedly misled investors about its meetings with the FDA, claiming that it was making progress in demonstrating the effectiveness and efficacy of its drug candidate, omburtamab. What was unknown to investors was that the FDA had repeatedly advised Y-mAbs that the treatment of effect of omburtamab cannot be objectively established or quantified based on a comparison between Study 03-133 and an external cohort comprised of data from the Central German Childhood Cancer Registry (CGCCR) database because of substantial differences in the patient populations, and the absence of tumor response data, and that Study 101 was neither sufficiently advanced nor indicative of efficacy to justify approval. Further, Y-mAbs failed to advise investors that it had elected to submit the March 31, 2022 BLA prior to reaching agreement with the FDA on the content of the application. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Y-mAbs, investors suffered damages.

To join the Y-mAbs class action, go to https://rosenlegal.com/submit-form/?case_id=9496 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8781499

March 5, 2023

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CRBU

NEW YORK, March 04, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Caribou Biosciences, Inc. (NASDAQ: CRBU): (i) pursuant and/or traceable to the offering documents and related prospectus issued in connection with the Company’s 2021 initial public offering conducted on or about July 23, 2021 (the “IPO” or “Offering”); and/or (ii) between July 23, 2021 and December 9, 2022, both dates inclusive (the “Class Period”), of the important April 11, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Caribou securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Caribou class action, go to https://rosenlegal.com/submit-form/?case_id=11988 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 11, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

DETAILS OF THE CASE: According to the lawsuit, Also according to the lawsuit, the Offering Documents and defendants made false and/or misleading statements and/or failed to disclose that: (1) CB-010’s treatment effect was not as durable as defendants had led investors to believe; (2) accordingly, CB-010’s clinical and commercial prospects were overstated; and (3) as a result, the Offering Documents and defendants’ public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Caribou class action, go to https://rosenlegal.com/submit-form/?case_id=11988 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

GlobeNewswire Distribution ID 8781524

March 5, 2023

Ruler of Fujairah leads UAE delegation to Fifth UN Conference on the Least Developed Countries

DOHA, As a representative of UAE President His Highness Sheikh Mohamed bin Zayed Al Nahyan, H.H. Sheikh Hamad bin Mohammed Al Sharqi, Supreme Council Member and Ruler of Fujairah, chaired the UAE delegation to the Fifth United Nations Conference on the Least Developed Countries (LDC5), which started today in Doha, Qatar. The five-day conference will be attended by a number of world leaders, and representatives of business sector, civil society and youth.

Abdullah bin Touq Al Marri, UAE Minister of Economy, and Mohammed Saeed Al Dhanhani, Director of the Emiri Court of Fujairah, attended the opening session of the conference.

In his keynote opening address, H.H. Sheikh Tamim ibn Hamad Al Thani, the Amir of Qatar, said,”We are confident that this conference, will contribute to supporting the least developed countries’ march towards achieving development therein for the next ten years.”

”It might be appropriate to revive the theme of the Secretary General of the United Nations: “No Poverty” in the world. The realization of this requires an international synergy to implement a human development plan at the global level,” he added.

The conference takes place every 10 years and this year’s meeting from 5 to 9 March 2023 will focus on returning the needs of the 46 designated countries to the top of the global agenda and supporting them as they strive to get back on track to sustainable development. The global conference seeks to accelerate sustainable development in the places where international assistance is needed the most – and to tap the full potential of the Least Developed Countries, helping them make progress on the road to prosperity.

Tariq Al Fahaam

Source:Emirates News Agency

March 5, 2023

UN Member States reach agreement to protect ocean life

NEW YORK, After more than 15 years of discussions, UN member states finally agreed Saturday to a text on the first international treaty after years of negotiations to protect the high seas, a fragile and vital treasure that covers nearly half the planet, according to media reports. “The ship has reached the shore,” conference chair Rena Lee announced at the UN headquarters in New York.

The treaty is seen as essential to conserving 30 percent of the world’s land and ocean by 2030, as agreed by world governments in a historic accord signed in Montreal in December.

The high seas begin at the border of countries’ exclusive economic zones, which extend up to 200 nautical miles (370 kilometres) from coastlines. They thus fall under the jurisdiction of no country.

Even though the high seas comprise more than 60 percent of the world’s oceans and nearly half the planet’s surface, they have long drawn far less attention than coastal waters and a few iconic species.

Ocean ecosystems create half the oxygen humans breathe and limit global warming by absorbing much of the carbon dioxide emitted by human activities.

But they are threatened by climate change, pollution and overfishing.

Only about one percent of the high seas are currently protected.

When the new treaty comes into force it will allow the creation of marine protected areas in these international waters.

The EU also announced $860 million for research, monitoring and conservation of oceans in 2023 at the Our Ocean conference in Panama that ended Friday. Panama said a total of $19 billion was pledged by countries.

Tariq Al Fahaam

Source:Emirates News Agency

March 5, 2023

Nahyan bin Mubarak opens the MENA Organisation for Rare Diseases Annual Meeting 2023 in Dubai

DUBAI, Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance and Coexistence, opened on Saturday the MENA Organisation for Rare Diseases Annual Meeting 2023 in Dubai.

Co-organised by the MENA Organisation for Rare Diseases and UAE Genetic Diseases Association, the three-day medical gathering is assembling 500 specialists and 100 speakers from 18 countries who will deliver the most updated knowledge in presentations, symposiums, and workshops related to rare diseases in various clinical fields including cardiology, pulmonary, neurology, oncology, metabolic, endocrine, pediatrics, and genetics.

The largest event for rare disease in the region will also emphasise on research, achievements, and latest advancements in diagnostics and therapeutics in rare diseases. The meeting will present awards to the best submitted abstracts, and several other awards.

Organisers say their goal is to bring all parties involved in rare diseases in one place to connect and exchange knowledge under one umbrella aiming to increase awareness, advance research, and provide better care for individuals with rare diseases.

Tariq Al Fahaam

Source:Emirates News Agency